analyst
RN
NASDAQ · RNA
Avidity Biosciences, Inc.
Healthcare · Biotechnology
$8.42
Up+$0.00 (+0.00%)
Updated Sep 30, 2026, 11:16 AM
SID Score
3.9/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 9.4B
- P/E ratio
- -20.36
- Dividend yield
- 0.00%
- 52-week range
- $8.05 – $73.06
- Volume
- 158.8K
- Avg. volume
- 5.22M
Price performance · RNA
RNA price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Sep 29, 2026
RNA closed at $8.42 after 20 trading sessions, down 38.85% for the selected period.
- Last close
- $8.42
- Period change
- -38.85%
- Period low
- $8.19
- Period high
- $14.60
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 29, 2026 | $8.42 | $8.50 | $8.21 | $8.42 | 158.8K |
| Sep 28, 2026 | $8.21 | $8.515 | $8.05 | $8.42 | 504.92K |
| Sep 25, 2026 | $8.20 | $8.365 | $8.10 | $8.29 | 221.43K |
| Sep 24, 2026 | $8.30 | $8.49 | $8.16 | $8.19 | 355.24K |
| Sep 23, 2026 | $9.22 | $9.31 | $8.29 | $8.33 | 434.52K |
| Sep 22, 2026 | $9.24 | $9.485 | $9.17 | $9.22 | 241.28K |
| Sep 21, 2026 | $8.97 | $9.34 | $8.9425 | $9.19 | 481.27K |
| Sep 18, 2026 | $9.57 | $9.665 | $8.66 | $8.95 | 1.04M |
| Sep 17, 2026 | $9.65 | $9.695 | $9.435 | $9.56 | 569.62K |
| Sep 16, 2026 | $10.11 | $10.11 | $9.50 | $9.50 | 356.44K |
| Sep 15, 2026 | $10.21 | $10.21 | $9.62 | $10.09 | 274.58K |
| Sep 14, 2026 | $10.37 | $10.71 | $10.15 | $10.21 | 255.71K |
| Sep 11, 2026 | $10.37 | $10.41 | $10.0041 | $10.36 | 247.5K |
| Sep 10, 2026 | $10.44 | $10.74 | $10.28 | $10.35 | 421.63K |
| Sep 9, 2026 | $11.20 | $11.20 | $10.34 | $10.51 | 690.44K |
| Sep 8, 2026 | $14.08 | $14.19 | $10.75 | $11.35 | 1.72M |
| Sep 4, 2026 | $14.51 | $14.65 | $14.01 | $14.19 | 167.79K |
| Sep 3, 2026 | $14.19 | $14.68 | $13.99 | $14.60 | 164.91K |
| Sep 2, 2026 | $13.77 | $14.098 | $13.76 | $14.06 | 111.64K |
| Sep 1, 2026 | $13.24 | $13.92 | $13.20 | $13.77 | 178.71K |
Latest RNA news
The latest Smart Investors Daily articles mentioning RNA.
Stock researchResearch & News · SEC Filings
Company
OverviewForecastEarnings — requires Earnings Calls and Results accessDividend — requires Dividend Research accessFinancials
Market Activity
OptionsInsider Trades — requires Insider Buying and Selling accessShort InterestInstitutional Ownership — requires Institutional Ownership accessSentiment
Research & News
Loading stock research…